UPDATE : Tuesday, October 15, 2019
상단여백
Seoul Medical Center transfer public healthcare know-how to developing countries by Lee Han-soo 2019-10-15 18:02
‘Genome analysis-based therapy to help realize precision medicine’ by Lee Han-soo 2019-10-15 17:50
'High ozone levels can aggravate dry eye symptoms' by Lee Han-soo 2019-10-15 17:50
Merck Korea forcefully shuts down general medicine biz by Kim Yun-mi 2019-10-15 15:51
Galderma Korea’s key strategy: choice and concentration by Kim Yun-mi 2019-10-15 13:56
라인
Korea brings up Fukushima’s radioactive water disposal issue at WHO by Lee Han-soo 2019-10-15 12:54
Medytox, Daewoong still in dispute over Nabota's spore appraisal by Lee Han-soo 2019-10-15 11:28
Kolon Life Science shares surge after TissueGene’s survival by Jeong Sae-im 2019-10-14 18:01
Lilly’s Taltz shows superiority to Tremfya in treating psoriasis patients by Lee Han-soo 2019-10-14 18:01
First lung disease reported here with suspected ties to vaping by Lee Han-soo 2019-10-14 18:01
라인
HLB merges with Elevar to own rivoceranib rights by Jeong Sae-im 2019-10-14 14:43
HanAll's Chinese partner ends P2 trial of dry eye treatment by Lee Han-soo 2019-10-14 14:08
[Special] How are Korean employees coping with big-pharma M&As? by Kim Yun-mi 2019-10-14 13:45
Sanofi releases data showing improved survival for prostate cancer treatment by Lee Han-soo 2019-10-14 12:16
Regulator keeps Kolon Tissuegene listed with 1-year grace period by Lee Han-soo 2019-10-12 09:41
라인
GC to market Merck's diabetes treatment by Lee Han-soo 2019-10-11 18:13
Bayer drugs out of stock in Korea by Lee Han-soo 2019-10-11 16:36
Drug regulator to hire 87 more reviewers next year by Lee Hye-seon 2019-10-11 16:35
Sanofi to cover part of Dupixent cost for atopic dermatitis patients by Kim Yun-mi 2019-10-11 15:13
‘Direct-to-consumer genetic testing needs preparation’ by Kim Eun-young 2019-10-11 15:12
여백
여백
여백
Back to Top